The Gut Microbiome, Inflammation, and Salt-Sensitive Hypertension

Area of Science:

• Cardiovascular Science
• Immunology
• Microbiome Research

Background:

• Salt sensitivity of blood pressure (SSBP) predicts cardiovascular death, affecting a significant portion of hypertensive and normotensive individuals.
• Reducing sodium intake is proven to lower blood pressure and cardiovascular events, yet precise mechanisms remain unclear.
• The gut microbiome's role in salt-induced inflammation and hypertension is increasingly recognized.

Purpose of the Study:

• To review the mechanisms of salt-induced cardiovascular disease.
• To elucidate the potential role of the gut microbiome in salt sensitivity of blood pressure (SSBP).

Main Methods:

• Review of existing literature on salt sensitivity, hypertension, and the gut microbiome.
• Analysis of immune system involvement in high-salt diet-induced hypertension.
• Exploration of the gut as a primary site for sodium absorption and microbial interaction.

Main Results:

• High-salt diets induce inflammation via immune cells like dendritic cells (DCs) and T cells, producing cytokines such as IL-6, IFN-γ, and IL-17A.
• Gut microbiome alterations are implicated in salt-induced hypertension.
• The gut microbiome's specific contribution to SSBP and its mechanisms require further investigation.

Conclusions:

• Targeting the gut microbiota and associated immune cell activation presents a promising therapeutic strategy for SSBP.
• Understanding the microbiome's role is crucial for developing novel treatments for salt-induced cardiovascular disease.
• Further research is needed to fully delineate the mechanisms linking gut dysbiosis to salt sensitivity.